Rolf Simons, of 3S Simons Security Systems GmbH, explains how a multi-layer approach can help secure the products along the entire supply chain and in all aspects; micro colour-code technology can decisively contribute to the success of all these endeavours.
Rebecca Vangenechten of Siemens argues that, while the pace of change will vary from company to company, all CMOs need to have a PAT strategy in place. PAT offers immense potential for pharmaceutical manufacturing.
This article by Harriet King of Biocair International focuses on bridging the gap between the logistics provider and the cool chain, a core element in the transportation of temperature-controlled pharmaceutical product.
In this second part of this series, Dr Rick Turner and Russell Reeve of Quintiles look into the concepts of interim analysis, and at the programme level.
Sven Stegemann, of Capsugel explores the use of a Flexible Technology Platform for Clinical Trial Manufacturing. The clinical programme is the most significant step in the product development process in terms of resources and time, and as such, is also a major area of interest to increase efficiency.
Instantly injectable, thermo-stable vaccines at tropical temperatures could make cold storage problems a thing of the past
The pioneering technology is based on two main platforms – VitRIS (Vitrified Readily Injectable Suspension) and HydRIS® (Hypodermic Rehydration Injection System). Nova also owns what is believed to be the world’s only fully validated cGMP aseptic spray-dryer for the production of clinical material. The facility will accelerate the time to market of VitRIS- based products, writes John Seaton of Nova Bio-Pharma Technologies Ltd.
Highlights from the 2010 event: A Review of the Past Five Years and A View of the Future, Wall Street’s 2010 Forecast and Analysis of Outsourcing Trends, Sourcing to Low Cost Regions: Panacea of Piece of The Puzzle.